Tara Bancroft
Stock Analyst at TD Cowen
(2.84)
# 1,781
Out of 4,918 analysts
8
Total ratings
66.67%
Success rate
27.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $28.72 | +74.09% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $53.48 | +21.54% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $12.35 | -10.93% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.21 | +726.45% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $66.93 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $8.02 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $28.72
Upside: +74.09%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $53.48
Upside: +21.54%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $12.35
Upside: -10.93%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.21
Upside: +726.45%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $66.93
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $8.02
Upside: -